2369 On Other Exchanges
Symbol
Exchange
2369 is not on other exchanges.

medibic group (2369) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDIBIC GROUP (2369)

Related News

No related news articles were found.

medibic group (2369) Related Businessweek News

No Related Businessweek News Found

medibic group (2369) Details

MediBIC Group provides healthcare and drug development services. It provides genetic testing services with diagnostic tools to doctors; GLP-compliant gene profiling services to pharmaceutical companies; and sample banking and management services, as well as focuses on providing health care services to pets. The company is also involved in developing a cell culture system; selling consumables; promoting licensing activities for the pancreatic cancer drug Glufosfamide; the research and development of pharmaceuticals and diagnostic agents, etc.; and providing data analysis for preventive health care, as well as clinical trial services to cell therapy. MediBIC Group was founded in 2000 and is headquartered in Tokyo, Japan.

17 Employees
Last Reported Date: 03/30/16
Founded in 2000

medibic group (2369) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

medibic group (2369) Key Developments

MediBIC Group To Be Delisted From Tokyo Stock Exchange

MediBIC Group will be delisted from Tokyo Stock Exchange, effective October 6, 2016. The delisting was due to the sales of a company is less than the required value.

MediBIC Group Reports Consolidated Earnings Results for the First Quarter Ended March 31, 2016; Provides Earnings Guidance for the Six Months Ending June 2016 and Fiscal Ending December 2016

MediBIC Group reported consolidated earnings results for the first quarter ended March 31, 2016. The company reported net sales of ¥52 million, operating loss of ¥114 million, net loss attributable to owners of parent of ¥112 million or ¥3.81 per share against net sales of ¥35 million, operating loss of ¥113 million, net loss attributable to owners of parent of ¥145 million or ¥4.98 per share a year ago. For the six months ending June 2016, the company expects net sales of ¥108 million, operating loss of ¥80 million, net loss attributable to owners of parent of ¥79 million or ¥2.72 per share. For the fiscal ending December 2016, the company expects net sales of ¥364 million, operating income of ¥5 million, net income attributable to owners of parent of ¥3 million or ¥0.12 per share.

MediBIC Group to Report Q1, 2016 Results on May 11, 2016

MediBIC Group announced that they will report Q1, 2016 results on May 11, 2016

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

2369 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2369.
View Industry Companies
 

Industry Analysis

2369

Industry Average

Valuation 2369 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.7x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MEDIBIC GROUP, please visit www.medibic.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.